06/01/2026
The announcement has already happened.
What comes next is understanding what it may mean for the future of cannabinoid products.
The Substance Access Beneficiary Engagement Incentive (BEI) is a pilot evaluating physician-supervised, hemp-derived CBD products in a more structured, outcomes-driven environment.
It’s early. It’s limited. And it’s not broad Medicare coverage.
But it does raise an important question for brands:
If cannabinoid products move closer to healthcare-oriented pathways, is your supply chain built for that future?
That’s the conversation we believe is worth having.
See bio for full blog post.